TARDBP and amyotrophic lateral sclerosis: demonstrated successful detection of elevated TDP‐43 levels, quantified using the SIMOA assay, in plasma EVs derived from patients with behavioral FTD due to TDP‐43 pathology and ALS, relative to controls.14